REFERENCES
1. Kim TH, Kim H, Joo I, Lee JM. Combined hepatocellular-cholangiocarcinoma: changes in the 2019 world health organization histological classification system and potential impact on imaging-based diagnosis. Korean J Radiol. 2020;21:1115.
2. Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17-48.
3. Stroescu C, Herlea V, Dragnea A, et al. The diagnostic value of cytokeratins and carcinoembryonic antigen immunostaining in differentiating hepatocellular carcinomas from intrahepatic cholangiocarcinomas. J Gastrointestin Liver Dis. 2006;15:9-14.
4. Lin DC, Mayakonda A, Dinh HQ, et al. Genomic and epigenomic heterogeneity of hepatocellular carcinoma. Cancer Res. 2017;77:2255-65.
5. Lu XY, Xi T, Lau WY, et al. Hepatocellular carcinoma expressing cholangiocyte phenotype is a novel subtype with highly aggressive behavior. Ann Surg Oncol. 2011;18:2210-7.
6. Cong WM, Bu H, Chen J, et al. Practice guidelines for the pathological diagnosis of primary liver cancer: 2015 update. World J Gastroenterol. 2016;22:9279.
7. Wang Y, Wang X, Huang X, et al. Integrated Genomic and Transcriptomic Analysis reveals key genes for predicting dual-phenotype Hepatocellular Carcinoma Prognosis. J. Cancer. 2021;12:2993-3010.
8. Takano M, Shimada K, Fujii T, et al. Keratin 19 as a key molecule in progression of human hepatocellular carcinomas through invasion and angiogenesis. BMC Cancer. 2016;16:903.
9. Kawai T, Yasuchika K, Ishii T, et al. Keratin 19, a cancer stem cell marker in human hepatocellular carcinoma. Clin Cancer Res. 2015;21:3081-91.
10. Lee JI. Prognosis of hepatocellular carcinoma expressing cytokeratin 19: comparison with other liver cancers. World J Gastroenterol. 2012;18:4751.
11. Govaere O, Komuta M, Berkers J, et al. Keratin 19: a key role player in the invasion of human hepatocellular carcinomas. Gut. 2014;63:674-85.
12. Liu MT, Zhang JY, Xu L, et al. A multivariate model based on gadoxetic acid-enhanced MRI using Li-RADS v2018 and other imaging features for preoperative prediction of dual‑phenotype hepatocellular carcinoma. Radiol med. 2023;128:1333-46.
13. Chen S, Feng S, Wei J, et al. Pretreatment prediction of immunoscore in hepatocellular cancer: a radiomics-based clinical model based on Gd-EOB-DTPA-enhanced MRI imaging. Eur Radiol. 2019;29:4177-87.
14. Gu HX, Huang XS, Xu JX, Zhu P, Xu JF, Fan SF. Diagnostic value of MRI features in dual-phenotype hepatocellular carcinoma: a preliminary study. J Digit Imaging. 2023;36:2554-66.
15. Feng Z, Li H, Liu Q, et al. CT radiomics to predict macrotrabecular-massive subtype and immune status in hepatocellular carcinoma. Radiology. 2023;307:e221291.
16. Ali MU, Kim KS, Khalid M, Farrash M, Zafar A, Lee SW. Enhancing Alzheimer’s disease diagnosis and staging: a multistage CNN framework using MRI. Front. Psychiatry. 2024;15:1395563.
17. Li M, Fan Y, You H, et al. Dual-energy CT deep learning radiomics to predict macrotrabecular-massive hepatocellular carcinoma. Radiology. 2023;308:e230255.
18. Chernyak V, Fowler KJ, Kamaya A, et al. Liver Imaging Reporting and Data System (LI-RADS) version 2018: imaging of hepatocellular carcinoma in at-risk patients. Radiology. 2018;289:816-30.
19. Wu Q, Yu YX, Zhang T, et al. Preoperative diagnosis of dual-phenotype hepatocellular carcinoma using enhanced MRI radiomics models. J Magn Reson Imaging. 2022;57:1185-96.
20. Rhee H, Kim H, Park YN. Clinico-radio-pathological and molecular features of hepatocellular carcinomas with keratin 19 expression. Liver Cancer. 2020;9:663-81.
21. Fatourou E, Koskinas J, Karandrea D, et al. Keratin 19 protein expression is an independent predictor of survival in human hepatocellular carcinoma. Eur J Gastroenterol Hepatol. 2015;27:1094-102.
22. Huang X, Long L, Wei J, et al. Radiomics for diagnosis of dual-phenotype hepatocellular carcinoma using Gd-EOB-DTPA-enhanced MRI and patient prognosis. J Cancer Res Clin Oncol. 2019;145:2995-3003.
23. Cai Y, Long Y, Han Z, et al. Swin Unet3D: a three-dimensional medical image segmentation network combining vision transformer and convolution. BMC Med Inform Decis Mak. 2023;23:33.
24. Wu M, Qian Y, Liao X, Wang Q, Heng PA. Hepatic vessel segmentation based on 3D swin-transformer with inductive biased multi-head self-attention. BMC Med Imaging. 2023;23:91.
25. Shamshad F, Khan S, Zamir SW, et al. Transformers in medical imaging: a survey. Med Image Anal. 2023;88:102802.
26. Liu Z, Lin Y, Cao Y, et al. Swin transformer: hierarchical vision transformer using shifted windows. In: 2021 IEEE/CVF International Conference on Computer Vision (ICCV); 2021 Oct 10-17; Montreal, Canada. IEEE; 2021. pp. 9992-10002.
27. He X, Xu Y, Zhou C, et al. Prediction of microvascular invasion and pathological differentiation of hepatocellular carcinoma based on a deep learning model. Eur J Radiol. 2024;172:111348.
28. Wang W, Wang Y, Song D, et al. A Transformer-Based microvascular invasion classifier enhances prognostic stratification in HCC following radiofrequency ablation. Liver Int. 2024;44:894-906.
29. Zhao L, Bao J, Wang X, et al. Detecting adverse pathology of prostate cancer with a deep learning approach based on a 3D swin-transformer Model and biparametric MRI: a multicenter retrospective study. J Magn Reson Imaging. 2023;59:2101-12.
30. Ali MU, Zafar A, Kim S, Kim KS, Lee SW. From task-specific to foundation models: a paradigm shift in medical vision-language analysis. Comput Sci Rev. 2026;59:100831.
31. Li L, Zhou X, Cui W, et al. Combining radiomics and deep learning features of intra-tumoral and peri-tumoral regions for the classification of breast cancer lung metastasis and primary lung cancer with low-dose CT. J Cancer Res Clin Oncol. 2023;149:15469-78.
32. Yang L, Xu P, Zhang Y, et al. A deep learning radiomics model may help to improve the prediction performance of preoperative grading in meningioma. Neuroradiology. 2022;64:1373-82.
33. Kim H, Choi GH, Na DC, et al. Human hepatocellular carcinomas with “Stemness”-related marker expression: keratin 19 expression and a poor prognosis. Hepatology. 2011;54:1707-17.
